A minimally invasive answer for a growing problem
Over 60 million Americans suffer from geastroesophageal reflux disease, better known as GERD and each year Americans spend over $42 billion on over the counter drugs to combat one of GERD’s major symptoms, heartburn. While these drugs may offer some relief they are not a permanent solution and may be hiding an even greater risk to your health, Esophageal cancer. Many studies have concluded that long term exposure of the esophagus lining to acid reflux can contribute to the onset of esophageal cancer. Many people do not even realize that they have the cancer until it’s too late due to the fact that their heartburn medication is concealing the warning signs and symptoms. Today there are solutions though and they could not only cure your chronic and debilitating heartburn, they could that save your life.
In Maryland, this procedure is performed only at Saint Agnes, by Dr. Averbach. Esophyx involves rebuilding the faulty valve between the stomach and esophagus. This malfunction allows stomach acid to flow the wrong way and creates the telltale symptoms of GERD: heartburn, regurgitation and difficulty swallowing. During Esophyx, an instrument is inserted through the mouth and down the esophagus, and Dr. Averbach rebuilds the defective fold.
Dr. Andrew Averbach, renowned in his field, brought this innovative procedure to our area, which restores the body’s natural protection against reflux providing long term success for the vast majority of patients.
Esophyx is an excellent option for those patients who have no signs of hernia. Fortunately, for those who do, there is still a minimally invasive option
If you are suffering from a digestive disorder please call us at 1-866-690-9355 or click here.
Meet Dr. Andrew Averbach
Dr. Averbach received his medical degree from N. Pirogov Medical School in Moscow, Russia in 1979. He completed training in general surgery and gastrointestinal oncology and practiced at Hertzen Cancer Research Institute until 1992, when he started a research fellowship at the Washington Hospital Center in Washington, D.C. Dr. Averbach graduated from the Saint Agnes Hospital surgical residency program in 2002.
Dr. Averbach is Director of Bariatric and Minimally Invasive Surgery at Saint Agnes Hospital, specializing in bariatric, laparoscopic and general surgery.
Dr. Averbach is a member of the American College of Surgeons and the American Society for Metabolic and Bariatric Surgery. He is board-certified by the American Board of Surgeons. He has published more than 80 articles on different topics of general, laparoscopic surgery and surgical oncology.